p21WAF1 mutation is not a predominant alteration in pediatric bone tumors

Pediatric Research

Volumn 43, Issue 3, 1998, Pages 393-395

  Patiño García, Ana ^a   Sotillo Piñeiro, Elena ^a   Sierrasesúmaga Ariznabarreta, Luis ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BONE TUMOR; CHILDHOOD CANCER; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; EWING SARCOMA; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; OSTEOSARCOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0344074556     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199803000-00014     Document Type: Article

References (17)

1. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D 1993 p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
2. 1 arrest and apoptosis. Cancer Res 54:1169-1174
3. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
4. Greenblatt MS, Bennett WP, Hollstein M, Harris CC 1994 Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
5. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R 1989 Allelotype of colorectal carcinomas. Science 244:207-211
6. Solomon E, Borrow J, Goddard AD 1991 Chromosome aberrations and cancer. Science 254:1153-1160
7. Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R 1995 Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 10:599-601
8. Koopmann J, Maintz D, Schild S, Schramm J, Louis DN, Wiestler OD, von Deimling, A 1995 Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours. Br J Cancer 72:1230-1233
9. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D-L, Vogelstein B, Koeffler P 1994 Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781-3784
10. Antillón-Klüssmann F, García-Delgado M, Villa Elízaga I, Sierrasesúcmaga L 1995 Mutational activation of ras genes is absent in pediatric osteosarcoma. Cancer Genet Cytogenet 79:49-53
11. Patiño-García A, Sierrasesúcmaga L 1997 Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients. Cancer Genet Cytogenet 96:1-6
12. Rogers BB, Alpert LC, Hine EA, Buffone GJ 1990 Analysis of DNA in fresh and fixed tissue by polymerase chain reaction. Am J Pathol 136:541-548
13. Myers R, Maniatis T, Lerman L 1987 Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501-527
14. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T 1994 Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54:3042-3048
15. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B 1996 Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10:1945-1952
16. 94 → Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. J Biol Chem 211:15782-15786
17. Gao X, Chen YQ, Wu N, Grignon DJ, Sakr W, Porter AT, Honn KV 1995 Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene 11:1395-1398